Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team are scheduled to participate in the upcoming investor conference, detailed below.
Van Lanschot Kempen conference
Event Date: April 16-17, 2024 | Amsterdam, Netherlands
| Press Release in English | 159.75 KB |
| Communiqué de presse en français | 103.07 KB |